IBDEI0PY ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,11666,1,4,0)
;;=4^Z52.4
;;^UTILITY(U,$J,358.3,11666,2)
;;=^5063082
;;^UTILITY(U,$J,358.3,11667,0)
;;=D47.Z1^^46^569^8
;;^UTILITY(U,$J,358.3,11667,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11667,1,3,0)
;;=3^Post-Transplant Lymphoproliferative Disorder (PTLD)
;;^UTILITY(U,$J,358.3,11667,1,4,0)
;;=4^D47.Z1
;;^UTILITY(U,$J,358.3,11667,2)
;;=^5002261
;;^UTILITY(U,$J,358.3,11668,0)
;;=N18.1^^46^570^1
;;^UTILITY(U,$J,358.3,11668,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11668,1,3,0)
;;=3^Chr Kidney Disease,Stage 1
;;^UTILITY(U,$J,358.3,11668,1,4,0)
;;=4^N18.1
;;^UTILITY(U,$J,358.3,11668,2)
;;=^5015602
;;^UTILITY(U,$J,358.3,11669,0)
;;=N18.2^^46^570^2
;;^UTILITY(U,$J,358.3,11669,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11669,1,3,0)
;;=3^Chr Kidney Disease,Stage 2
;;^UTILITY(U,$J,358.3,11669,1,4,0)
;;=4^N18.2
;;^UTILITY(U,$J,358.3,11669,2)
;;=^5015603
;;^UTILITY(U,$J,358.3,11670,0)
;;=N18.4^^46^570^6
;;^UTILITY(U,$J,358.3,11670,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11670,1,3,0)
;;=3^Chr Kidney Disease,Stage 4
;;^UTILITY(U,$J,358.3,11670,1,4,0)
;;=4^N18.4
;;^UTILITY(U,$J,358.3,11670,2)
;;=^5015605
;;^UTILITY(U,$J,358.3,11671,0)
;;=N18.5^^46^570^7
;;^UTILITY(U,$J,358.3,11671,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11671,1,3,0)
;;=3^Chr Kidney Disease,Stage 5
;;^UTILITY(U,$J,358.3,11671,1,4,0)
;;=4^N18.5
;;^UTILITY(U,$J,358.3,11671,2)
;;=^5015606
;;^UTILITY(U,$J,358.3,11672,0)
;;=N18.9^^46^570^8
;;^UTILITY(U,$J,358.3,11672,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11672,1,3,0)
;;=3^Chr Kidney Disease,Unspec
;;^UTILITY(U,$J,358.3,11672,1,4,0)
;;=4^N18.9
;;^UTILITY(U,$J,358.3,11672,2)
;;=^332812
;;^UTILITY(U,$J,358.3,11673,0)
;;=N18.6^^46^570^9
;;^UTILITY(U,$J,358.3,11673,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11673,1,3,0)
;;=3^ESRD
;;^UTILITY(U,$J,358.3,11673,1,4,0)
;;=4^N18.6
;;^UTILITY(U,$J,358.3,11673,2)
;;=^303986
;;^UTILITY(U,$J,358.3,11674,0)
;;=N19.^^46^570^10
;;^UTILITY(U,$J,358.3,11674,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11674,1,3,0)
;;=3^Kidney Failure,Unspec
;;^UTILITY(U,$J,358.3,11674,1,4,0)
;;=4^N19.
;;^UTILITY(U,$J,358.3,11674,2)
;;=^5015607
;;^UTILITY(U,$J,358.3,11675,0)
;;=N18.30^^46^570^3
;;^UTILITY(U,$J,358.3,11675,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11675,1,3,0)
;;=3^Chr Kidney Disease,Stage 3,Unspec
;;^UTILITY(U,$J,358.3,11675,1,4,0)
;;=4^N18.30
;;^UTILITY(U,$J,358.3,11675,2)
;;=^5159286
;;^UTILITY(U,$J,358.3,11676,0)
;;=N18.31^^46^570^4
;;^UTILITY(U,$J,358.3,11676,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11676,1,3,0)
;;=3^Chr Kidney Disease,Stage 3a
;;^UTILITY(U,$J,358.3,11676,1,4,0)
;;=4^N18.31
;;^UTILITY(U,$J,358.3,11676,2)
;;=^5159287
;;^UTILITY(U,$J,358.3,11677,0)
;;=N18.32^^46^570^5
;;^UTILITY(U,$J,358.3,11677,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11677,1,3,0)
;;=3^Chr Kidney Disease,Stage 3b
;;^UTILITY(U,$J,358.3,11677,1,4,0)
;;=4^N18.32
;;^UTILITY(U,$J,358.3,11677,2)
;;=^5159288
;;^UTILITY(U,$J,358.3,11678,0)
;;=N10.^^46^571^5
;;^UTILITY(U,$J,358.3,11678,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,11678,1,3,0)
;;=3^Acute Tubulo-Interstitial Nephritis
;;^UTILITY(U,$J,358.3,11678,1,4,0)
;;=4^N10.
;;^UTILITY(U,$J,358.3,11678,2)
;;=^5015570
;;^UTILITY(U,$J,358.3,11679,0)
;;=N17.1^^46^571^1
;;^UTILITY(U,$J,358.3,11679,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0PY 3791 printed Dec 13, 2024@01:53:29 Page 2
IBDEI0PY ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,11666,1,4,0)
+2 ;;=4^Z52.4
+3 ;;^UTILITY(U,$J,358.3,11666,2)
+4 ;;=^5063082
+5 ;;^UTILITY(U,$J,358.3,11667,0)
+6 ;;=D47.Z1^^46^569^8
+7 ;;^UTILITY(U,$J,358.3,11667,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,11667,1,3,0)
+10 ;;=3^Post-Transplant Lymphoproliferative Disorder (PTLD)
+11 ;;^UTILITY(U,$J,358.3,11667,1,4,0)
+12 ;;=4^D47.Z1
+13 ;;^UTILITY(U,$J,358.3,11667,2)
+14 ;;=^5002261
+15 ;;^UTILITY(U,$J,358.3,11668,0)
+16 ;;=N18.1^^46^570^1
+17 ;;^UTILITY(U,$J,358.3,11668,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,11668,1,3,0)
+20 ;;=3^Chr Kidney Disease,Stage 1
+21 ;;^UTILITY(U,$J,358.3,11668,1,4,0)
+22 ;;=4^N18.1
+23 ;;^UTILITY(U,$J,358.3,11668,2)
+24 ;;=^5015602
+25 ;;^UTILITY(U,$J,358.3,11669,0)
+26 ;;=N18.2^^46^570^2
+27 ;;^UTILITY(U,$J,358.3,11669,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,11669,1,3,0)
+30 ;;=3^Chr Kidney Disease,Stage 2
+31 ;;^UTILITY(U,$J,358.3,11669,1,4,0)
+32 ;;=4^N18.2
+33 ;;^UTILITY(U,$J,358.3,11669,2)
+34 ;;=^5015603
+35 ;;^UTILITY(U,$J,358.3,11670,0)
+36 ;;=N18.4^^46^570^6
+37 ;;^UTILITY(U,$J,358.3,11670,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,11670,1,3,0)
+40 ;;=3^Chr Kidney Disease,Stage 4
+41 ;;^UTILITY(U,$J,358.3,11670,1,4,0)
+42 ;;=4^N18.4
+43 ;;^UTILITY(U,$J,358.3,11670,2)
+44 ;;=^5015605
+45 ;;^UTILITY(U,$J,358.3,11671,0)
+46 ;;=N18.5^^46^570^7
+47 ;;^UTILITY(U,$J,358.3,11671,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,11671,1,3,0)
+50 ;;=3^Chr Kidney Disease,Stage 5
+51 ;;^UTILITY(U,$J,358.3,11671,1,4,0)
+52 ;;=4^N18.5
+53 ;;^UTILITY(U,$J,358.3,11671,2)
+54 ;;=^5015606
+55 ;;^UTILITY(U,$J,358.3,11672,0)
+56 ;;=N18.9^^46^570^8
+57 ;;^UTILITY(U,$J,358.3,11672,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,11672,1,3,0)
+60 ;;=3^Chr Kidney Disease,Unspec
+61 ;;^UTILITY(U,$J,358.3,11672,1,4,0)
+62 ;;=4^N18.9
+63 ;;^UTILITY(U,$J,358.3,11672,2)
+64 ;;=^332812
+65 ;;^UTILITY(U,$J,358.3,11673,0)
+66 ;;=N18.6^^46^570^9
+67 ;;^UTILITY(U,$J,358.3,11673,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,11673,1,3,0)
+70 ;;=3^ESRD
+71 ;;^UTILITY(U,$J,358.3,11673,1,4,0)
+72 ;;=4^N18.6
+73 ;;^UTILITY(U,$J,358.3,11673,2)
+74 ;;=^303986
+75 ;;^UTILITY(U,$J,358.3,11674,0)
+76 ;;=N19.^^46^570^10
+77 ;;^UTILITY(U,$J,358.3,11674,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,11674,1,3,0)
+80 ;;=3^Kidney Failure,Unspec
+81 ;;^UTILITY(U,$J,358.3,11674,1,4,0)
+82 ;;=4^N19.
+83 ;;^UTILITY(U,$J,358.3,11674,2)
+84 ;;=^5015607
+85 ;;^UTILITY(U,$J,358.3,11675,0)
+86 ;;=N18.30^^46^570^3
+87 ;;^UTILITY(U,$J,358.3,11675,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,11675,1,3,0)
+90 ;;=3^Chr Kidney Disease,Stage 3,Unspec
+91 ;;^UTILITY(U,$J,358.3,11675,1,4,0)
+92 ;;=4^N18.30
+93 ;;^UTILITY(U,$J,358.3,11675,2)
+94 ;;=^5159286
+95 ;;^UTILITY(U,$J,358.3,11676,0)
+96 ;;=N18.31^^46^570^4
+97 ;;^UTILITY(U,$J,358.3,11676,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,11676,1,3,0)
+100 ;;=3^Chr Kidney Disease,Stage 3a
+101 ;;^UTILITY(U,$J,358.3,11676,1,4,0)
+102 ;;=4^N18.31
+103 ;;^UTILITY(U,$J,358.3,11676,2)
+104 ;;=^5159287
+105 ;;^UTILITY(U,$J,358.3,11677,0)
+106 ;;=N18.32^^46^570^5
+107 ;;^UTILITY(U,$J,358.3,11677,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,11677,1,3,0)
+110 ;;=3^Chr Kidney Disease,Stage 3b
+111 ;;^UTILITY(U,$J,358.3,11677,1,4,0)
+112 ;;=4^N18.32
+113 ;;^UTILITY(U,$J,358.3,11677,2)
+114 ;;=^5159288
+115 ;;^UTILITY(U,$J,358.3,11678,0)
+116 ;;=N10.^^46^571^5
+117 ;;^UTILITY(U,$J,358.3,11678,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,11678,1,3,0)
+120 ;;=3^Acute Tubulo-Interstitial Nephritis
+121 ;;^UTILITY(U,$J,358.3,11678,1,4,0)
+122 ;;=4^N10.
+123 ;;^UTILITY(U,$J,358.3,11678,2)
+124 ;;=^5015570
+125 ;;^UTILITY(U,$J,358.3,11679,0)
+126 ;;=N17.1^^46^571^1
+127 ;;^UTILITY(U,$J,358.3,11679,1,0)
+128 ;;=^358.31IA^4^2
